EAHP learning modules
A number of modules for self-assessment are now available online via BMJ Learning. Aimed at hospital pharmacists and based on recordings of satellite events held at the annual European Association of Hospital Pharmacists (EAHP) Congress, they are free to access and accredited by the Accreditation Council for Pharmacy Education (ACPE).
The events were financially supported by different external organisations but totally independent of industry involvement, with the faculty and the topics selected by the EAHP scientific committee.
All users must complete a one-time registration on BMJ Learning and subsequently log in on every visit using their username and password to access modules and their CPD record. Accreditation is only valid for 2 years from the date of publication. Printable CPD certificates are available to users that achieve the minimum pass mark and complete a survey at the end of the course. 1.5-2 ACPE credits will be awarded, depending on the length of the course.
Oral anticoagulant therapy is used to reduce the risk of stroke in patients with atrial fibrillation (AF) and pharmacists have an important role in educating patients about and managing treatment with oral anticoagulants. In this course three pharmacist practitioners members of iPACT (International Pharmacists for Anticoagulation Care Taskforce) present projects outlining how oral anticoagulants can be employed to improve the care of patients suffering from AF.
Optimal oral anticoagulant therapy requires careful consideration of patient’s needs and an understanding of the efficacy, safety, pharmacokinetics of the anticoagulants and the methods used to measure their effects. This course enables pharmacists to stay updated with new anticoagulant drugs, educate patients about their drugs, and highlight the importance of adhering to anticoagulant therapy.
Biologicals and biosimilars
Tackles the challenges of switching from a reference biological medicine to a biosimilar, including safety and efficacy concerns, tendering procedures, and medicines shortages. Identifies the problems, shows examples, and discusses the way forward, so that the full potential of biosimilars as enablers of affordable innovation can be fulfilled, with maximum advantages for patients and healthcare providers.
Provides the key information on biosimilar approval in the EU as applied to cancer therapy. By understanding the concepts and facts, hospital pharmacists will be enabled to provide a scientific, unbiased approach with a focus on patient care in a world of limited resources. By gaining insights on into the regulatory assessment process and the clinician’s perspective in prescribing biosimilars, the ability of hospital pharmacists to advise on how to implement biosimilars of monoclonal antibodies used in cancer therapy will be strengthened.
Offers insights into the evolution of biologicals, which are an essential treatment option for a variety of diseases in current medicine. Course participants will learn about the development and authorisation of biosimilars as well as the quality criteria of biologicals. In addition, issues of switching and interchangeability of biologicals will be addressed to provide an in-depth understanding of key principles regarding quality, safety and efficacy.
Biosimilars of targeted breast cancer biologic drugs will soon be introduced into the market, and it will be essential for hospital pharmacists to understand the key concepts in order to manage their implementation. This module gives pharmacists a better understanding of the biosimilar approval process in the EU, the role of biosimilars in reducing therapeutic cost in breast cancer, and how to work with other healthcare providers, stakeholders and patients to manage their implementation.
Management and leadership
Explores the differences between management and leadership, including topics such as strategic planning, efficiency, team building, process mapping, problem solving and also human factors, vision and buy-in, change management, motivating people and managing resistance. Introduces the use of established management tools that can be used for practical implementation of the principles discussed.
Politics and healthcare policy
Discusses how Brexit and the Falsified Medicines Directive will impact the supply of medicines and medicines policy in the EU. Considers what hospital pharmacists can do to prepare for these changes and identify new procedures to prevent the possible negative effects on access to medicines.
Elaborates on the factors that create or exacerbate medicines shortages around the world, and outlines how hospital pharmacists can collaborate with other stakeholders to detect, reduce and avoid shortages, taking into account strategic and quality issues along the medicines supply chain.
Describes what qualitative is, when it should be used, how to conduct it ethically, the different methods that can be employed and how their results can be analysed. Explains why this research methodology is important in the evaluation of complex interventions and services.
Further information from EAHP (coming soon)
Therapeutic drug monitoring
Explains how to use therapeutic drug monitoring (TDM) to optimise and individualise therapy. Presents practical advice on identifying drugs that are good candidates for TDM, appropriate indications for TDM, and understanding and interpreting drug concentrations. Emphasises the importance of a multidisciplinary team approach.